Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mazindol pilot phase II study in children with ADHD
2006-006816-31Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Mazindol ER in attention deficit hyperactivity disorder (ADHD) (2 cohorts), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in ADHD Rating Scale severity score. Started Mar 2007; status: active.
02
Drugs
Mazindol ER
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2006-006816-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006816-31.